Brief Summary
See package insert for full Prescribing Information. For further product information and current
package insert, please visit XYNTHA.com or call Pfizer Inc toll-free at 1-800-879-3477.
INDICATIONS AND USAGE
Control and Prevention of Bleeding Episodes in Patients with Hemophilia A
XYNTHA Antihemophilic Factor (Recombinant) is indicated in adults and children with
hemophilia A (congenital factor VIII deficiency or classic hemophilia) for control and prevention
of bleeding episodes. XYNTHA does not contain von Willebrand factor, and therefore is not
indicated in patients with von Willebrand’s disease.
Perioperative Management in Patients with Hemophilia A
XYNTHA Antihemophilic Factor (Recombinant) is indicated in adults and children with
hemophilia A for perioperative management.
DOSAGE FORMS AND STRENGTHS
XYNTHA is supplied as a white to off-white freeze-dried powder in the following dosages:
250 IU, 500 IU, 1000 IU, 2000 IU, 3000 IU.
CONTRAINDICATIONS
Do not use in patients who have manifested life-thr VFV